Xeljanz Clinical Trials
Here are the 6 most popular medical studies for xeljanz
Benzodiazepine
Tofacitinib + Lorazepam + IVIG for Down Syndrome Regression Disorder
Recruiting1 awardPhase 2
Los Angeles, California
This trial looks at treatments for Down Syndrome Regression Disorder, a condition seen in adolescents and young adults with Down Syndrome that can cause hallucinations, delusions, aggression, and difficulty with daily activities.
Upadacitinib for Rheumatoid Arthritis
Recruiting3 awardsPhase 4
Birmingham, Alabama
This trial is designed to see if briefly holding certain medications around the time of getting a booster COVID-19 vaccine dose improves the response to the vaccine, with safety concerns for the effects of the autoimmune disease in mind.
Popular filter options for xeljanz trials
Phase 3 Clinical Trials
View 20 phase 3 medical studies.
Janus Kinase (JAK) Inhibitor
Second Line Induction Therapy + Healthy Diet for Ulcerative Colitis
Recruiting2 awardsPhase 3
Miami, Florida
This trial will study whether the Fasting Mimicking diet can help improve the effectiveness of tofacitinib or ustekinumab therapy in people with ulcerative colitis, by measuring clinical response and changes in fecal calprotectin and C-reactive protein levels.
Disease-modifying antirheumatic drugs (DMARDs)
DMARDs for Rheumatoid Arthritis
Recruiting2 awardsPhase 3
Omaha, Nebraska
This trial is testing whether a certain type of arthritis medication can help predict clinical responses to other types of arthritis medication. All patients will receive a starting dose of the medication being tested, which may be adjusted by the investigator as needed. If a subject becomes intolerant to the medication being tested, the subject will be withdrawn from the study. Data from the study will be collected at the end of the trial.
Clinical Trials With No Placebo
View 20 medical studies that do not have a placebo group.
Monoclonal Antibodies
Vedolizumab + Tofacitinib for Ulcerative Colitis
Recruiting3 awardsPhase 4
Los Angeles, California
This trial will test the effectiveness of vedolizumab+tofacitinib and vedolizumab alone in treating adults with moderate-severe UC. Participants will receive vedolizumab+tofacitinib for 8 weeks and then be monitored for response. Those who show response will receive vedolizumab alone for 44 weeks.
View More Xeljanz Trials
See another 2 many medical studies focused on xeljanz.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.